TerminatedNot Applicable

Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children

Stopped: terminated

47 participantsStarted 2007-05

Plain-language summary

The purpose of this study is planned to investigate whether small doses of methylprednisolone pulse macrolide therapy can relieve symptoms,chest X-rays faster than macrolide alone therapy for refractory mycoplasma pneumoniae pneumonia(MPP) .

Who can participate

Age range3 Years – 11 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * mycoplasma pneumoniae pneumonia * prolonged fever and deterioration of radiological findings despite macrolides treatment for 7 days or more. Exclusion Criteria: * chronic cardiac and pulmonary disease * immunodeficiency * requiring mechanical ventilation * with other pathogens detected during pneumonia.

What they're measuring

efficacy of methylprednisolone pulse macrolide therapy for children with refractory MPP.

Timeframe: 3-year

Trial details

NCT IDNCT01217099

SponsorChongqing Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-05

View on ClinicalTrials.gov More Refractory Mycoplasma Pneumoniae Pneumonia trials